WHITEPAPER
The Latest MHC Class I & II Deficient In Vivo Platform Humanised with PBMCs

In this whitepaper you'll learn:

• The benefits of the JAX NSG^TM-MHC I/II KO mouse platform humanised with pre-characterised PBMCs
• How this platform can support a wide range of immunological studies, especially those containing T cells responses
• The versatility of this platform to various research disciplines

Brought to you by